Patents by Inventor John A. Birkett

John A. Birkett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9127311
    Abstract: The present invention relates to compositions and methods that allow the manipulation of the catalytic activity of multi-component nucleic acid complexes. Further, the invention provides methods which use these compositions and methods to create molecular sensors, molecular switches, and/or modulators or propagators of autocatalytic self-replicating cascades and other iterative processes. More particularly, the invention relates to compositions allowing self-assembly of active and inactive multicomponent nucleic acid complexes, methods of making such compositions, and methods for use.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: September 8, 2015
    Assignee: SpeeDx Pty Ltd
    Inventors: Alison Velyian Todd, Elisa Mokany, Donald John Birkett, Tram Bich Doan, Christopher Roland Reid
  • Patent number: 8394946
    Abstract: The present invention relates to Multicomponent Nucleic Acid Enzymes (MNAzymes) and methods for their use. MNAzymes comprise two or more oligonucleotide components which self-assemble in the presence of one or more MNAzyme assembly facilitator molecules to form a catalytically active structure. Compositions for making MNAzymes, and collections of MNAzymes are provided. Also provided are methods for using MNAzymes for the detection, identification and/or quantification of one or more targets. The methods can be practiced in solution-based assays or in assays where one or more reaction components are attached to a support structure. The methods allow for multiplexing the MNAzyme detection to detect multiple targets in a single reaction. Also provided are kits for making the compositions, and for practicing the methods provided herein.
    Type: Grant
    Filed: October 6, 2006
    Date of Patent: March 12, 2013
    Assignee: Speedx Pty Ltd
    Inventors: Alison Velyian Todd, Donald John Birkett, Tram Bich Doan, Elisa Mokany
  • Publication number: 20120101267
    Abstract: The present invention relates to Multicomponent Nucleic Acid Enzymes (MNAzymes) and methods for their use. MNAzymes comprise two or more oligonucleotide components which self-assemble in the presence of one or more MNAzyme assembly facilitator molecules to form a catalytically active structure which may have cleavage, ligase or other enzymatic activity. Compositions for making MNAzymes and collections of MNAzymes are provided, together with uses thereof. Also provided are methods for using MNAzymes for the detection, identification and/or quantification of one or more targets. The methods can be practiced in solution-based assays or in assays where one or more reaction components are attached to a support structure. The methods allow for multiplexing the MNAzyme detection to detect multiple targets in a single reaction. Also provided are kits for making the compositions, and for practicing the methods provided herein.
    Type: Application
    Filed: April 5, 2007
    Publication date: April 26, 2012
    Inventors: Alison Velyian Todd, Elisa Mokany, Donald John Birkett, Tram Bich Doan, Paul Ean Young
  • Patent number: 8097715
    Abstract: Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. The multitargeting interfering RNA molecules have two strands that target multiple target sites on one or more pre-selected RNA molecules. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation.
    Type: Grant
    Filed: May 21, 2008
    Date of Patent: January 17, 2012
    Assignee: Johnson & Johnson Research PTY Limited
    Inventors: Laurent Pierre Rivory, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20100286238
    Abstract: The present invention concerns methods and reagents useful in decreasing the level of or severity of respiratory infection or disease due to paramyxoviruses, such as RSV or HPIV, or coronavirus infection. Particularly, the invention relates to modulating gene expression using a multitargeting interfering RNA molecules that target multiple target sites on one or more pre-selected RNA molecules.
    Type: Application
    Filed: May 14, 2008
    Publication date: November 11, 2010
    Inventors: Laurent Pierre Rivory, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20090312399
    Abstract: The present invention relates to guanosine-rich oligonucleotides having the capacity to induce cell death, having characteristics of programmed cell death, in non-quiescent cells of higher eukaryotic organisms. The invention also relates to therapeutic methods involving the administration of these nucleic acid molecules to subjects suffering from, or being predisposed to, disorders involving abnormal cell proliferation and migration. The invention also concerns pharmaceutical compositions comprising the guanosine-rich nucleic acid molecules, in association with suitable carriers.
    Type: Application
    Filed: June 28, 2006
    Publication date: December 17, 2009
    Applicant: JOHNSON & JOHNSON RESEARCH PTY, LTD
    Inventors: Laurent Pierre Rivory, Donald John Birkett
  • Publication number: 20090239816
    Abstract: Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation.
    Type: Application
    Filed: May 21, 2008
    Publication date: September 24, 2009
    Applicant: Johnson & Johnson Research PTY. Limited
    Inventors: Laurent Pierre Rivory, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20090192103
    Abstract: Interfering RNA molecules are now designed and produced with specificity for multiple binding sequences present in distinct genetic contexts in one or more pre-selected target RNA molecules and are used to modulate expression of the target sequences. The multitargeting interfering RNA molecules have two strands that target multiple target sites on one or more pre-selected RNA molecules. Such a multitargeting interfering RNA approach provides a powerful tool for gene regulation.
    Type: Application
    Filed: May 21, 2008
    Publication date: July 30, 2009
    Applicant: Johnson & Johnson Research PTY. Limited
    Inventors: Laurent Pierre RIVORY, Michael Poidinger, Donald John Birkett, Gregory Martin Arndt, Toby Passioura
  • Publication number: 20080250977
    Abstract: The present invention relates to an antiskinning composition containing an organic oxygen scavenger and at least one drying accelerator.
    Type: Application
    Filed: April 16, 2007
    Publication date: October 16, 2008
    Inventors: Andrew Mason, John Birkett, Paul Thomas
  • Patent number: 5302527
    Abstract: The invention relates to use of the nitrate reductase gene as a selection marker in transformations of the antibiotic-producing species Penicillium chrysogenum and Acremonium chrysogenum. In particular it relates to a process for obtaining cells of Penicillium chrysogenum or Acremonium chrysogenum capable of expressing nitrate reductase from cells of the same species which are initially deficient in expression of the nitrate reductase gene (niaD-cells), which comprises introducing into said niaD-cells vector DNA including a marker gene coding for nitrate reductase operatively linked to a control sequence for expression of said gene within the selected host cells, followed by selection of cells thus transformed by their ability to grow on a suitable medium containing nitrate as the only source of nitrogen and to vector DNA for use in such a process.
    Type: Grant
    Filed: November 9, 1990
    Date of Patent: April 12, 1994
    Assignee: Glaxo Group Limited
    Inventors: John A. Birkett, James R. Kinghorn
  • Patent number: D563561
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: March 4, 2008
    Assignee: Symmetry Medical, Inc.
    Inventors: Valentine T. Faust, III, Daniel L. Sands, John Birkett